Conversely, TLR2−/− mice treated with AOM-DSS have been shown to have an increased tumor incidence with rampant proliferation and dampened apoptosis, although TLR2 deletion under normal conditions shows a reduced proliferation and increased apoptosis in IECs (Lowe et al., 2010). The gene discussed is TLR2; the disease is neoplasm.